Literature DB >> 21142699

Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo.

Corinna E Zimmermann1, Matthias Gierloff, Jürgen Hedderich, Yahya Açil, Joerg Wiltfang, Hendrik Terheyden.   

Abstract

This study was designed to trace bone marrow-derived stromal cells (MSC) after implantation in an ectopic rat model of bone tissue engineering. MSC were isolated from adult donor rats, expanded, seeded on a hydroxyapatite/β-tricalcium phosphate bone graft substitute (Straumann® BoneCeramic), and cultivated until confluent. Before subcutaneous implantation of seeded constructs and controls (unseeded bone graft substitute) in isogenic rats (n = 32), cells were labeled with the fluorescent dye carboxyfluoresceine-diacetate-succinimidyl-ester. Specimens were harvested at sacrifice on day 1, 3, 7, or 14 after implantation (n = 8 per group) and processed for histology (hematoxylin and eosin, CD68, 4',6-diamidino-2-phenylindol). Carboxyfluoresceine-diacetate-succinimidyl-ester-labeled transplanted cells were quantified in decalcified sections (50 fields of view per specimen) at 488 nm. Over time, transplanted cells decreased in number from 31.3 ± 2.3 (day 1) to 9.2 ± 1.1 (day 3) and 0.3 ± 0.1 (day 7) (p < 0.001). Fourteen days postimplantation MSC could no longer be identified. Additionally, starting on day 3 postimplantation, cellular disintegration was noted. Multinucleated giant cells were present in constructs and controls on day 7 and increased to day 14 postimplantation. These results indicate that ectopically transplanted MSC survive for a rather short time after implantation. Possible reasons for early cell death are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21142699     DOI: 10.1089/ten.TEA.2009.0577

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  38 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Survival of aging CD264+ and CD264- populations of human bone marrow mesenchymal stem cells is independent of colony-forming efficiency.

Authors:  Sean D Madsen; Sean H Jones; H Alan Tucker; Margaret K Giler; Dyllan C Muller; Carson T Discher; Katie C Russell; Georgina L Dobek; Mimi C Sammarco; Bruce A Bunnell; Kim C O'Connor
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

3.  Osseointegrative properties of electrospun hydroxyapatite-containing nanofibrous chitosan scaffolds.

Authors:  Michael E Frohbergh; Anya Katsman; Mark J Mondrinos; Collin T Stabler; Kurt D Hankenson; Jeffrey T Oristaglio; Peter I Lelkes
Journal:  Tissue Eng Part A       Date:  2014-12-16       Impact factor: 3.845

4.  Osteoinductivity of gelatin/β-tricalcium phosphate sponges loaded with different concentrations of mesenchymal stem cells and bone morphogenetic protein-2 in an equine bone defect model.

Authors:  Jong-Pil Seo; Nao Tsuzuki; Shingo Haneda; Kazutaka Yamada; Hidefumi Furuoka; Yasuhiko Tabata; Naoki Sasaki
Journal:  Vet Res Commun       Date:  2014-01-18       Impact factor: 2.459

5.  Augmented migration of mesenchymal stem cells correlates with the subsidiary CXCR4 variant.

Authors:  Asieh Heirani-Tabasi; Hojjat Naderi-Meshkin; Maryam M Matin; Mahdi Mirahmadi; Mina Shahriyari; Naghmeh Ahmadiankia; Nasser Sanjar Moussavi; Hamid Reza Bidkhori; Mahmood Raeesolmohaddeseen; Ahmad Reza Bahrami
Journal:  Cell Adh Migr       Date:  2018-02-27       Impact factor: 3.405

6.  The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.

Authors:  Melanie Rodrigues; Cecelia C Yates; Austin Nuschke; Linda Griffith; Alan Wells
Journal:  Tissue Eng Part A       Date:  2013-05-01       Impact factor: 3.845

7.  Templated repair of long bone defects in rats with bioactive spiral-wrapped electrospun amphiphilic polymer/hydroxyapatite scaffolds.

Authors:  Artem B Kutikov; Jordan D Skelly; David C Ayers; Jie Song
Journal:  ACS Appl Mater Interfaces       Date:  2015-02-19       Impact factor: 9.229

8.  In vivo gene activity of human mesenchymal stem cells after scaffold-mediated local transplantation.

Authors:  Soon Jung Hwang; Tae Hyung Cho; In Sook Kim
Journal:  Tissue Eng Part A       Date:  2014-04-28       Impact factor: 3.845

9.  Synergistic enhancement of ectopic bone formation by supplementation of freshly isolated marrow cells with purified MSC in collagen-chitosan hydrogel microbeads.

Authors:  Joel K Wise; Andrea I Alford; Steven A Goldstein; Jan P Stegemann
Journal:  Connect Tissue Res       Date:  2015-09-04       Impact factor: 3.417

10.  In vitro comparison of different carrier materials with rat bone marrow MSCs.

Authors:  M Gierloff; T Nitsche; S Adam-Klages; K Liebs; J Hedderich; V Gassling; J Wiltfang; D Kabelitz; Y Açil
Journal:  Clin Oral Investig       Date:  2013-03-06       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.